Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3067% above fair value
$20.15−0.35 (-1.71%)
Close on Nov 19, 2026Market cap $1.94BP/E –Yield –
Fortrea net income
Net income is the profit left for shareholders after every expense, interest and tax.
Fortrea's net income for the twelve months ending Sep 30, 2026 was -$68.70M. For fiscal 2025 it was -$986.20M. The highest annual figure on record is $186.20M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$986.20M | – |
| FY2024 | Dec 31, 2024 | -$328.50M | – |
| FY2023 | Dec 31, 2023 | -$25.20M | -113.5% |
| FY2022 | Dec 31, 2022 | $186.20M | +90.0% |
| FY2021 | Dec 31, 2021 | $98.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $600.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$13.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$32.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$374.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$562.90M | – |
| Q4 FY2024 | Dec 31, 2024 | -$61.20M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.90M | – |
| Q2 FY2024 | Jun 30, 2024 | -$138.40M | -549.4% |
| Q1 FY2024 | Mar 31, 2024 | -$101.00M | -908.0% |
| Q4 FY2023 | Dec 31, 2023 | -$54.50M | -304.1% |
| Q3 FY2023 | Sep 30, 2023 | -$14.00M | -123.1% |
| Q2 FY2023 | Jun 30, 2023 | $30.80M | -53.6% |
| Q1 FY2023 | Mar 31, 2023 | $12.50M | -61.5% |
| Q4 FY2022 | Dec 31, 2022 | $26.70M | – |
| Q3 FY2022 | Sep 30, 2022 | $60.60M | – |
| Q2 FY2022 | Jun 30, 2022 | $66.40M | – |
| Q1 FY2022 | Mar 31, 2022 | $32.50M | – |
See a number that looks wrong?